ArticleDrug safety2008

Cardiovascular safety and overall tolerability of solifenacin in routine clinical use: a 12-week, open-label, post-marketing surveillance study.

Martin C Michel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.